Impact of Peer Education Program on Headache Disorders

Headache Disorder Clinical Trial

Official title:

Impact of Peer Education Program on Headache Disorders in Rural Communities, India: a Quasi-experimental Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02677935
• Other study ID #: nmp/22182
• Status: Completed
• Phase: N/A
• First received: February 5, 2016
• Last updated: February 8, 2016
• Start date: January 2015
• Est. completion date: January 2016

Study information

• Verified date: February 2016
• Source: NMP Medical Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Worldwide, headache disorders are among the most common medical conditions. Many people with headache need not experience further pain if the diagnosis and treatment are correct. Most patients do not have correct diagnosis and treatment. This study tested a model for treatment of people with headache disorders at primary health-care level in rural areas of Haryana, India.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 360
• Est. completion date: January 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• All residents of the Region Kaithal (haryana) may apply for recruitment

• Primary headache disorders including tension type headache, migraine

Exclusion Criteria:

• Planning to move the area

• Refused to consent

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Headache
• Headache Disorder
• Headache Disorders

Intervention

Other:
• Community education programs

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
NMP Medical Research Institute	Kaithal Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reduction in number of days per month with headache after 12 months		From baseline to 12 months	No
Secondary	Reduction in number of days per month of over the counter drugs after 12 months		From Baseline to 12 Months	No